UniProt ID | TRI13_HUMAN | |
---|---|---|
UniProt AC | O60858 | |
Protein Name | E3 ubiquitin-protein ligase TRIM13 | |
Gene Name | TRIM13 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 407 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein . Concentrates and colocalizes with p62/SQSTM1 and ZFYVE1 at the perinuclear endoplasmic reticulum. |
|
Protein Description | Endoplasmic reticulum (ER) membrane anchored E3 ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. Enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal degradation. Regulates ER stress-induced autophagy, and may act as a tumor suppressor. [PubMed: 22178386 Plays also a role in innate immune response by stimulating NF-kappa-B activity in the TLR2 signaling pathway. Ubiquitinates TRAF6 via the 'Lys-29'-linked polyubiquitination chain resulting in NF-kappa-B activation] | |
Protein Sequence | MELLEEDLTCPICCSLFDDPRVLPCSHNFCKKCLEGILEGSVRNSLWRPAPFKCPTCRKETSATGINSLQVNYSLKGIVEKYNKIKISPKMPVCKGHLGQPLNIFCLTDMQLICGICATRGEHTKHVFCSIEDAYAQERDAFESLFQSFETWRRGDALSRLDTLETSKRKSLQLLTKDSDKVKEFFEKLQHTLDQKKNEILSDFETMKLAVMQAYDPEINKLNTILQEQRMAFNIAEAFKDVSEPIVFLQQMQEFREKIKVIKETPLPPSNLPASPLMKNFDTSQWEDIKLVDVDKLSLPQDTGTFISKIPWSFYKLFLLILLLGLVIVFGPTMFLEWSLFDDLATWKGCLSNFSSYLTKTADFIEQSVFYWEQVTDGFFIFNERFKNFTLVVLNNVAEFVCKYKLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
32 | Ubiquitination | CSHNFCKKCLEGILE CCCCHHHHHHHHHHH | 45.28 | - | |
35 (in isoform 3) | Ubiquitination | - | 54.37 | - | |
45 | Phosphorylation | LEGSVRNSLWRPAPF HHCCHHHCCCCCCCC | 20.81 | 24719451 | |
53 | Ubiquitination | LWRPAPFKCPTCRKE CCCCCCCCCCCCCCC | 37.94 | - | |
56 (in isoform 3) | Ubiquitination | - | 34.12 | - | |
74 | Phosphorylation | NSLQVNYSLKGIVEK CCCEEEEEHHHHHHH | 20.57 | 24719451 | |
81 | Ubiquitination | SLKGIVEKYNKIKIS EHHHHHHHHHCCCCC | 43.14 | - | |
90 | Ubiquitination | NKIKISPKMPVCKGH HCCCCCCCCCCCCCC | 49.39 | - | |
125 | Ubiquitination | ATRGEHTKHVFCSIE CCCCCCCEEEEEEHH | 39.41 | - | |
128 (in isoform 3) | Ubiquitination | - | 2.43 | - | |
166 | Phosphorylation | SRLDTLETSKRKSLQ HHHHHHHHHHHHHHH | 42.53 | - | |
167 | Phosphorylation | RLDTLETSKRKSLQL HHHHHHHHHHHHHHH | 22.53 | - | |
168 (in isoform 1) | Ubiquitination | - | 71.86 | 21906983 | |
168 | Ubiquitination | LDTLETSKRKSLQLL HHHHHHHHHHHHHHH | 71.86 | 21906983 | |
170 | Ubiquitination | TLETSKRKSLQLLTK HHHHHHHHHHHHHHC | 60.29 | - | |
171 (in isoform 2) | Ubiquitination | - | 25.94 | 21906983 | |
171 (in isoform 3) | Ubiquitination | - | 25.94 | - | |
171 | Phosphorylation | LETSKRKSLQLLTKD HHHHHHHHHHHHHCC | 25.94 | 29214152 | |
173 (in isoform 3) | Ubiquitination | - | 41.33 | - | |
174 | Phosphorylation | SKRKSLQLLTKDSDK HHHHHHHHHHCCHHH | 8.76 | 27251275 | |
176 | Phosphorylation | RKSLQLLTKDSDKVK HHHHHHHHCCHHHHH | 41.20 | - | |
183 | Ubiquitination | TKDSDKVKEFFEKLQ HCCHHHHHHHHHHHH | 55.32 | - | |
186 (in isoform 3) | Ubiquitination | - | 9.44 | - | |
188 | Ubiquitination | KVKEFFEKLQHTLDQ HHHHHHHHHHHHHHH | 48.57 | - | |
192 | Phosphorylation | FFEKLQHTLDQKKNE HHHHHHHHHHHHHHH | 21.04 | 29396449 | |
196 | Ubiquitination | LQHTLDQKKNEILSD HHHHHHHHHHHHHHH | 58.18 | - | |
202 | Phosphorylation | QKKNEILSDFETMKL HHHHHHHHHHHHHHH | 46.01 | 29759185 | |
206 | Phosphorylation | EILSDFETMKLAVMQ HHHHHHHHHHHHHHH | 21.43 | 29759185 | |
208 | Ubiquitination | LSDFETMKLAVMQAY HHHHHHHHHHHHHHH | 40.49 | - | |
221 (in isoform 1) | Ubiquitination | - | 49.10 | 21906983 | |
221 | Ubiquitination | AYDPEINKLNTILQE HHCHHHHHHHHHHHH | 49.10 | 21906983 | |
224 (in isoform 2) | Ubiquitination | - | 33.24 | 21906983 | |
224 (in isoform 3) | Ubiquitination | - | 33.24 | - | |
258 | Ubiquitination | QMQEFREKIKVIKET HHHHHHHHCCHHCCC | 43.50 | - | |
270 | Phosphorylation | KETPLPPSNLPASPL CCCCCCCCCCCCCCC | 49.40 | 25002506 | |
275 | Phosphorylation | PPSNLPASPLMKNFD CCCCCCCCCCCCCCC | 19.34 | 25850435 | |
279 | Ubiquitination | LPASPLMKNFDTSQW CCCCCCCCCCCCHHC | 63.24 | - | |
290 (in isoform 1) | Ubiquitination | - | 55.57 | 21906983 | |
290 | Ubiquitination | TSQWEDIKLVDVDKL CHHCCCEEEEECCCC | 55.57 | 2190698 | |
293 (in isoform 2) | Ubiquitination | - | 54.02 | 21906983 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI13_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI13_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ROBO2_HUMAN | ROBO2 | physical | 21900206 | |
GDIR1_HUMAN | ARHGDIA | physical | 21900206 | |
SQSTM_HUMAN | SQSTM1 | physical | 22178386 | |
ZFYV1_HUMAN | ZFYVE1 | physical | 22178386 | |
TERA_HUMAN | VCP | physical | 17314412 | |
AT2A2_HUMAN | ATP2A2 | physical | 17314412 | |
OST48_HUMAN | DDOST | physical | 17314412 | |
UB2D2_HUMAN | UBE2D2 | physical | 17314412 | |
TRI13_HUMAN | TRIM13 | physical | 17314412 | |
NEMO_HUMAN | IKBKG | physical | 25152375 | |
GMCL1_HUMAN | GMCL1 | physical | 25416956 | |
MDM2_HUMAN | MDM2 | physical | 21333377 | |
AKT1_HUMAN | AKT1 | physical | 21333377 | |
TRI13_HUMAN | TRIM13 | physical | 21333377 | |
ELOV2_HUMAN | ELOVL2 | physical | 28514442 | |
NPL4_HUMAN | NPLOC4 | physical | 28514442 | |
CKAP4_HUMAN | CKAP4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...